Sg Americas Securities, LLC Theravance Biopharma, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 15,853 shares of TBPH stock, worth $156,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,853

Previous 162,388 90.24%

Holding current value

$156,310

Previous $1.38 Million 90.7%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$7.66 - $10.25 $1.12 Million - $1.5 Million	-146,535 Reduced 90.24%	15,853 $128,000
Q2 2024 Jul 12, 2024	SELL	$8.29 - $9.92 $391,105 - $468,005	-47,178 Reduced 22.51%	162,388 $1.38 Million
Q1 2024 May 06, 2024	BUY	$8.22 - $11.59 $102,421 - $144,411	12,460 Added 6.32%	209,566 $1.88 Million
Q4 2023 Jan 12, 2024	SELL	$8.58 - $11.4 $476,215 - $632,734	-55,503 Reduced 21.97%	197,106 $2.22 Million
Q3 2023 Oct 13, 2023	BUY	$8.38 - $10.44 $850,360 - $1.06 Million	101,475 Added 67.14%	252,609 $2.18 Million
Q2 2023 Jul 10, 2023	BUY	$10.16 - $11.92 $1.23 Million - $1.44 Million	121,126 Added 403.65%	151,134 $1.56 Million
Q1 2023 Apr 28, 2023	BUY	$9.87 - $11.44 $144,111 - $167,035	14,601 Added 94.77%	30,008 $326,000
Q4 2022 Feb 02, 2023	SELL	$9.65 - $11.34 $114,429 - $134,469	-11,858 Reduced 43.49%	15,407 $173,000
Q3 2022 Oct 31, 2022	BUY	$8.39 - $10.22 $80,267 - $97,774	9,567 Added 54.06%	27,265 $276,000
Q2 2022 Jul 29, 2022	BUY	$8.41 - $10.34 $148,840 - $182,997	17,698 New	17,698 $160,000
Q1 2022 Apr 29, 2022	SELL	$8.33 - $12.96 $180,852 - $281,374	-21,711 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$7.42 - $11.05 $128,046 - $190,689	-17,257 Reduced 44.29%	21,711 $240,000
Q3 2021 Nov 01, 2021	BUY	$6.77 - $14.41 $209,369 - $445,643	30,926 Added 384.56%	38,968 $288,000
Q2 2021 Aug 12, 2021	BUY	$14.52 - $22.46 $116,769 - $180,623	8,042 New	8,042 $117,000
Q1 2021 May 13, 2021	SELL	$16.57 - $21.08 $699,751 - $890,208	-42,230 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$14.89 - $20.16 $628,804 - $851,356	42,230 New	42,230 $750,000
Q3 2020 Nov 09, 2020	SELL	$14.79 - $22.49 $246,149 - $374,301	-16,643 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$20.64 - $30.69 $238,082 - $354,009	-11,535 Reduced 40.94%	16,643 $349,000
Q1 2020 Apr 30, 2020	BUY	$17.84 - $31.21 $395,031 - $691,083	22,143 Added 366.91%	28,178 $651,000
Q4 2019 Jan 28, 2020	BUY	$16.12 - $25.89 $97,284 - $156,246	6,035 New	6,035 $156,000
Q2 2019 Jul 29, 2019	SELL	$15.6 - $25.15 $107,484 - $173,283	-6,890 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$22.57 - $28.15 $155,507 - $193,953	6,890 New	6,890 $156,000
Q2 2018 Aug 07, 2018	SELL	$22.06 - $25.52 $117,954 - $136,455	-5,347 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$23.37 - $29.71 $124,959 - $158,859	5,347 New	5,347 $130,000
Q4 2017 Jan 24, 2018	SELL	$25.82 - $35.66 $233,955 - $323,115	-9,061 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$23.88 - $34.96 $216,376 - $316,772	9,061	9,061 $310,000

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Theravance Biopharma, Inc. Transaction History